会议审议通过了以下议案： A 股简称:招商银行 A 股代码:600036 公告编号:2025-045 招商银行股份有限公司 监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 招商银行股份有限公司（简称本公司或招商银行）于 2025 年 8 月 25 日以电 子邮件方式发出第十二届监事会第四十三次会议通知，于 8 月 27 日以书面传签 方式召开会议。会议应表决监事 6 名，实际表决监事 6 名，总有效表决票为 6 票。 会议的召开符合《中华人民共和国公司法》和《招商银行股份有限公司章程》等 有关规定。 三、审议通过了《关于调整招商银行与董监高及其关联方开展关联交易审议 程序的议案》。 同意：6 票 反对：0 票 弃权：0 票 四、审议通过了《关于副行长离任审计结论的议案》，同意对王小青先生担 任招商银行副行长期间履职情况的离任审计结论。 同意：6 票 反对：0 票 弃权：0 票 特此公告。 招商银行股份有限公司监事会 2025 年 8 月 27 日 一、审议通过了《反洗钱与制裁合规政策（第三版）》。 同意：6 票 ...

同意：13 票 反对：0 票 弃权：0 票 A 股简称：招商银行 A 股代码：600036 公告编号：2025-044 招商银行股份有限公司 董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 招商银行股份有限公司（简称本公司或招商银行）于 2025 年 8 月 25 日以电子邮件方式发出第十三届董事会第三次会议通知，于 8 月 27 日以书面传签方式召开会议。会议应参会董事 13 名，实际参会 董事 13 名。会议的召开符合《中华人民共和国公司法》和《招商银 行股份有限公司章程》等有关规定。 会议审议通过了以下议案： 一、审议通过了《关联交易管理办法（第七版）》。 五、审议通过了《2025 年上半年全行内部审计工作情况和下半 年工作计划》。 同意：13 票 反对：0 票 弃权：0 票 本公司董事会审计委员会已审议通过本议案，并同意将其提交本 公司董事会审议。 特此公告。 二、审议通过了《关于调整招商银行与董监高及其关联方开展关 联交易审议程序的议案》。 同意：13 票 反对：0 票 弃权：0 票 三、审议通过了《 ...

泰康中证智能电动汽车交易型开放式指数 证券投资基金 基金管理人：泰康基金管理有限公司 基金托管人：招商银行股份有限公司 送出日期：2025 年 8 月 28 日 智能车 TK2025 年中期报告 基金管理人的董事会及董事保证本报告所载资料不存在虚假记载、误导性陈述或重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带的法律责任。本中期报告已经三分之二以 上独立董事签字同意，并由董事长签发。 基金托管人招商银行股份有限公司根据本基金合同规定，于 2025 年 8 月 27 日复核了本报告 中的财务指标、净值表现、利润分配情况、财务会计报告、投资组合报告等内容，保证复核内容 不存在虚假记载、误导性陈述或者重大遗漏。 基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈利。 基金的过往业绩并不代表其未来表现。投资有风险，投资者在作出投资决策前应仔细阅读本 基金的招募说明书及其更新。 本报告财务资料未经审计。 本报告期为 2025 年 1 月 1 日起至 2025 年 6 月 30 日止。 第 2页 共 55页 智能车 TK2025 年中期报告 第 3页 共 55页 智能车 TK20 ...

Fund Overview - The fund is named "TaiKang National Public Health and Medical Health Exchange-Traded Open-Ended Index Securities Investment Fund" and is managed by TaiKang Fund Management Co., Ltd. [2] - The fund's main code is 159760, and it was established on December 6, 2021, with trading commencing on December 20, 2021 [2]. - The fund aims to closely track the performance of its benchmark index, the National Public Health and Health Index, with a goal of minimizing tracking deviation and error [2][3]. Financial Performance - As of June 30, 2025, the fund's total net asset value was approximately 80.06 million RMB, with a net asset value per share of 0.5871 RMB [3][19]. - The fund reported a realized loss of approximately 11.16 million RMB for the period, with a profit of 1.25 million RMB [3][19]. - The weighted average net profit rate for the period was 1.50%, and the net value growth rate was 1.63% [3][19]. Investment Strategy - The fund primarily employs a full replication strategy to construct its stock investment portfolio based on the composition and weight of the benchmark index [2][11]. - The fund may also invest in fixed-income instruments to ensure liquidity and enhance investment returns [2][11]. - The fund's investment strategy includes hedging through stock index futures to improve investment efficiency while controlling risks [2][11]. Market Context - The macroeconomic environment in the first half of 2025 showed structural differentiation, with resilience in certain sectors like exports and manufacturing, while real estate cooled down after an initial recovery [10][14]. - The overall equity market experienced fluctuations, with the Shanghai Composite Index rising by 2.76% and the Hang Seng Index increasing by 20.18% during the same period [10][14]. - The pharmaceutical sector is expected to benefit from a series of policy incentives aimed at supporting the development of innovative drugs, marking a significant opportunity for investment in this area [14][10]. Management and Compliance - TaiKang Fund Management Co., Ltd. has been compliant with relevant laws and regulations, ensuring fair treatment of all funds under its management [9][10]. - The fund management has established a fair trading system and monitoring processes to prevent any conflicts of interest [9][10]. - The fund's valuation process is overseen by a dedicated valuation team, ensuring transparency and adherence to regulatory standards [14][15].

A 股简称:招商银行 A 股代码:600036 公告编号:2025-045 招商银行股份有限公司 监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 招商银行股份有限公司（简称本公司或招商银行）于 2025 年 8 月 25 日以电 子邮件方式发出第十二届监事会第四十三次会议通知，于 8 月 27 日以书面传签 方式召开会议。会议应表决监事 6 名，实际表决监事 6 名，总有效表决票为 6 票。 会议的召开符合《中华人民共和国公司法》和《招商银行股份有限公司章程》等 有关规定。 会议审议通过了以下议案： 一、审议通过了《反洗钱与制裁合规政策（第三版）》。 同意：6 票 反对：0 票 弃权：0 票 二、审议通过了《关联交易管理办法（第七版）》。 同意：6 票 反对：0 票 弃权：0 票 三、审议通过了《关于调整招商银行与董监高及其关联方开展关联交易审议 程序的议案》。 同意：6 票 反对：0 票 弃权：0 票 四、审议通过了《关于副行长离任审计结论的议案》，同意对王小青先生担 任招商银行副行长期间履职情况的离任审计结 ...

证券之星消息，8月27日股份制银行板块较上一交易日下跌1.74%，光大银行领跌。当日上证指数报收于 3800.35，下跌1.76%。深证成指报收于12295.07，下跌1.43%。股份制银行板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600036 | 招商银行 | 43.00 | -1.19% | 75.81万 | 32.81亿 | | 601998 | 中信银行 | 7.91 | -1.37% | 80.08万 | 6.35亿 | | 601166 | 兴业银行 | 22.50 | -1.66% | 68.86万 | 15.63亿 | | 600000 | 浦发银行 | 13.75 | -2.00% | 76.98万 | 10.66亿 | | 600015 | 华夏银行 | 7.71 | -2.03% | 59.52万 | 4.62亿 | | 601916 | 浙商银行 | 3.26 | -2.10% | 226.90万 | 7.471乙 | | 000001 | 平 ...

专利摘要显示，本申请公开了一种基础数据实时化计算方法、设备及计算机程序产品，涉及流数据处理 技术领域，所述方法包括：接收多样化数据源输入的基础数据，并基于实时计算引擎将所述基础数据进 行拆分分流，得到多批子流数据；根据预先构建的实时化计算逻辑对关联维度信息后的多批子流数据进 行实时化计算，得到实时计算结果；将所述实时计算结果进行数据差异化存储，并采用读写分离方式和 双集群写入方式将所述数据差异化存储的结果写入独立数据库集群。综合对基础数据进行拆分分流，预 先构建的实时化计算逻辑以及数据差异化存储、读写分离、双集群写入，实现高效地AUM基础数据实 时化计算。 天眼查资料显示，招商银行股份有限公司，成立于1987年，位于深圳市，是一家以从事货币金融服务为 主的企业。企业注册资本2521984.5601万人民币。通过天眼查大数据分析，招商银行股份有限公司共对 外投资了929家企业，参与招投标项目5000次，财产线索方面有商标信息1327条，专利信息1822条，此 外企业还拥有行政许可355个。 金融界2025年8月27日消息，国家知识产权局信息显示，招商银行股份有限公司申请一项名为"基础数据 实时化计算方法、设备及 ...

Core Viewpoint - The announcement details the establishment of the Xingye Hengtai Bond Fund, highlighting its successful fundraising and the qualifications of its fund managers [1][2]. Fund Information - Fund Name: Xingye Hengtai Bond Fund - Fund Code: 023811 - Fund Type: Contractual open-end fund - Effective Date of Fund Contract: August 26, 2025 - Fund Manager: Xingye Fund Management Co., Ltd. - Fund Custodian: China Merchants Bank Co., Ltd. [2] Fundraising Details - Total Net Subscription Amount: ¥1,330,252,328.44 - Interest Earned During Fundraising Period: ¥372,799.19 - Total Fund Shares: 1,330,625,127.63 shares - Number of Valid Subscription Accounts: 4,042 [1][2] Fund Manager Background - Fund Manager Zhou Ming has experience in fund investment and corporate annuity investment, previously working at Tianxiang Investment Consulting Co., Ltd. and other financial institutions - Fund Manager Tang Dingxiang served as a bond analyst at Everbright Securities and has been with Xingye Fund Management since August 2013 [1].

Core Insights - The total market financing balance reached 2.19 trillion yuan as of August 26, with an increase of 191.90 billion yuan from the previous trading day, marking three consecutive days of growth in financing balance [1] - Among individual stocks, 2025 stocks received net financing purchases on August 26, with 765 stocks having net purchases exceeding 10 million yuan, and 53 stocks exceeding 100 million yuan [1] - The top net financing purchase was for Shenghong Technology, with a net purchase of 1.042 billion yuan, followed by Cambricon and Zhongke Shuguang with net purchases of 593 million yuan and 542 million yuan, respectively [1] Individual Stock Analysis - The average financing balance as a percentage of circulating market value for stocks with significant net purchases was 4.23%, with Jianghuai Automobile having the highest ratio at 10.30% [2] - The top net financing purchases on August 26 included: - Shenghong Technology: net purchase of 1.042 billion yuan, latest financing balance of 935.54 million yuan, 4.95% of circulating market value [2] - Cambricon: net purchase of 593 million yuan, latest financing balance of 885.16 million yuan, 1.59% of circulating market value [2] - Zhongke Shuguang: net purchase of 542 million yuan, latest financing balance of 825.18 million yuan, 6.18% of circulating market value [2] Industry Distribution - The industries with the highest concentration of stocks receiving net financing purchases exceeding 100 million yuan were electronics, computers, and non-bank financials, with 15, 5, and 4 stocks respectively [1] - In terms of board distribution, 34 stocks on the main board, 11 on the ChiNext board, and 8 on the Sci-Tech Innovation board received significant net purchases [1]

Group 1 - The article highlights various promotional offers for new credit card users, including gifts such as brand bags, train tickets, and Starbucks coffee [5][8][11]. - It emphasizes the benefits of co-branded credit cards, such as the JD.com co-branded card offering up to 2 years of JD PLUS membership for new users [10]. - The article mentions the referral program, where both the referrer and the referred can receive rewards upon meeting certain criteria [20]. Group 2 - The article outlines the exciting privileges for cardholders, including discounts on dining and the ability to redeem points for various gifts [19]. - It provides information on how existing cardholders can apply for additional credit cards, noting that the credit limit will be shared with existing cards [22]. - The article encourages users to explore other credit card options available through the bank's platform [24].